The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...
From a treatment algorithm perspective, the 2024 AGA guidelines now recommend etrasimod as a high-efficacy option for biologic-naive patients and lower-efficacy for those with prior advanced therapy ...
AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
Everyday Health on MSN
Can prebiotics in food treat ulcerative colitis? Here’s what you need to know
Learn how prebiotics, or foods with compounds that support a healthy balance of gut bacteria (microbiome), may benefit people ...
An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...
A 52-week phase 3 clinical trial of Skyrizi, or risankizumab — a drug initially approved to treat Crohn’s disease, psoriatic arthritis and psoriasis — was shown to also achieve clinical remission in ...
Everyday Health on MSN
How to ease ulcerative colitis symptoms during a flare
Ease the symptoms of a UC flare, such as diarrhea, abdominal pain, and fever using expert-backed tips, and learn when to seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback